` TCMD (Tactile Systems Technology Inc) vs S&P 500 Comparison - Alpha Spread

TCMD
vs
S&P 500

Over the past 12 months, TCMD has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's 8% growth.

Stocks Performance
TCMD vs S&P 500

Loading

Performance Gap
TCMD vs S&P 500

Loading
TCMD
S&P 500
Difference

Performance By Year
TCMD vs S&P 500

Loading
TCMD
S&P 500
Add Stock

Competitors Performance
Tactile Systems Technology Inc vs Peers

Tactile Systems Technology Inc
Glance View

Market Cap
342.7m USD
Industry
Health Care

Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

TCMD Intrinsic Value
16.16 USD
Undervaluation 11%
Intrinsic Value
Price
Back to Top